Executive Summary
HHS data reveals $364M in CMS-heavy contracts (2/3 total value) signaling sustained demand for program integrity and IT services through 2027, with 2 bullish awards showing 55-95% outlays indicating execution momentum. Small businesses captured all via full/open competition, highlighting sector competitiveness. Neutral FDA bridge contract tempers IT upside but flags transition risks post-2025.
Tracking the trend? Catch up on the prior All HHS Contracts digest from December 30, 2025.
Investment Signals(2)
- CMS commits $267M to integrity/IT with high outlays(HIGH)▲
QLARANT ($177M obligation, 55% outlayed) and EXECUTIVE INFO ($74M, 95% outlayed) secure long-term CMS revenue to 2026-27, base+options up to $338M.
- FDA IT bridge nears completion(HIGH)▲
HUMANTOUCH $58M help desk at 89% outlayed, low remaining obligation signals wind-down by 2025-end.
Risk Flags(2)
- Execution[MEDIUM RISK]▼
Firm fixed price on 2/3 contracts ($152M) risks margin squeeze if costs overrun post-high outlays.
- Market[HIGH RISK]▼
Unexercised options ($60M potential) and bridge nature expose to non-renewal by 2025-27.
Opportunities(2)
- ◆
$60M unexercised options across contracts, plus extensions to 2026-27.
- ◆
Small biz dominance (3/3 awards) in HHS IT/integrity via open competition.
Sector Themes(2)
- ◆
73% value to CMS for UPIC and SaaS/help desk, 70%+ outlays signal multi-year execution.
- ◆
All awards to small/minority firms despite no set-asides, high obligations executed.
Watch List(3)
- 👁
{"entity"=>"QLARANT INTEGRITY SOLUTIONS LLC", "reason"=>"Largest award ($244M ceiling) with award-fee upside to 2027.", "trigger"=>"Option exercise >$67M or extension notice"}
- 👁
{"entity"=>"EXECUTIVE INFORMATION SYSTEMS, L.L.C.", "reason"=>"95% outlayed on $94M SaaS ceiling, near-term options key.", "trigger"=>"$20M options exercised by 2025-end"}
- 👁
{"entity"=>"HUMANTOUCH LLC", "reason"=>"Bridge wind-down risks follow-on loss post-$52M outlay.", "trigger"=>"FDA RFP for help desk successor"}
Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 3 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC